2399 — Biostar Microtech International Income Statement
0.000.00%
Last trade - 00:00
- TWD4.09bn
- TWD2.80bn
- TWD2.34bn
- 16
- 16
- 70
- 21
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,673 | 2,105 | 2,775 | 2,236 | 2,344 |
Cost of Revenue | |||||
Gross Profit | 115 | 253 | 520 | 269 | 135 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,799 | 2,131 | 2,558 | 2,235 | 2,474 |
Operating Profit | -126 | -26.9 | 217 | 1.53 | -130 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.8 | 182 | 407 | 16.2 | -117 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32.7 | 141 | 362 | 12.9 | -113 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 7.42 | 143 | 362 | 12.9 | -113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 7.42 | 143 | 362 | 12.9 | -113 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.466 | 0.593 | 2.01 | 0.072 | -0.636 |
Dividends per Share |